Freestone Grove Partners’s Concentrix CNXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-402
Closed -$11K 1077
2026
Q1
$11K Sell
402
-31,714
-99% -$1.13M ﹤0.01% 871
2025
Q4
$1.34M Buy
+32,116
New +$1.3M 0.01% 435

Other funds holding CNXC

Freestone Grove Partners's CNXC Position: Q2 2026 in Review

Freestone Grove Partners sold out of Concentrix (CNXC) in Q2 2026, closing a stake of 402 shares — an estimated $11K sold.

Freestone Grove Partners first reported a position in CNXC in Q4 2025 and held it in 2 quarters. The position peaked at $1.34M in Q4 2025. 273 funds tracked by Wall St. Rank hold CNXC as of Q2 2026.

  • Freestone Grove Partners reported no remaining Concentrix position as of Q2 2026 after selling out during the quarter.
  • Freestone Grove Partners sold 402 Concentrix shares in Q2 2026, an estimated $11K.
  • Freestone Grove Partners first reported a position in Concentrix in Q4 2025 and held it in 2 quarters.
  • Freestone Grove Partners's Concentrix position peaked at $1.34M in Q4 2025.
  • 273 funds tracked by Wall St. Rank held Concentrix as of Q2 2026.

Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.